SynthesisPediatric nephrology (Berlin, Germany)2025
Silent lupus nephritis: a pediatric center experience of baseline kidney biopsies and review of the published evidence.
Synthesis in Pediatric nephrology (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Investigation of the association between retinal microcirculation and renal function in children with lupus nephritis.Clinical rheumatology · 2026Article
- Assessing kidney outcomes in childhood-onset lupus nephritis: role of National Institutes of Health-modified histological indices.Clinical and experimental pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSilent lupus nephritis (sLN) describes the histopathological presence of nephritis in systemic lupus erythematosus (SLE) without evident clinical or biochemical kidney manifestations. Kidney biopsy practises in suspected sLN vary widely among centers. We report three cases of sLN from our center and review existing literature on sLN prevalence and the role of baseline kidney biopsies.
methodsCharacteristics of three patients with childhood-onset (cSLE) sLN from our center, including clinical and laboratory features as well as kidney biopsy findings, are reported. A systematic literature review was performed to evaluate the prevalence of proliferative LN among patients with sLN. Relevant studies were identified using a predefined search strategy on Ovid, MEDLINE, EMBASE, CINAHL Plus, Scopus, and Web of Science. Publications meeting inclusion criteria and reporting baseline kidney biopsy results with histopathological classification were included.
resultsThree cSLE patients with sLN from our center who underwent baseline kidney biopsies revealing class III LN in two and class II LN in one. The systematic review identified 4153 potential articles, of which 37 studies met inclusion criteria describing 639 patients with sLN; patients were aged 2-70 years. Among them, 30% had proliferative LN (class III, class IV) or class V, while 70% had class I or II LN.
conclusionsSignificant histologic LN findings are observed in 30% of SLE patients without overt kidney disease; frequently associated with high-titer dsDNA, anti-Smith antibodies, and/or hypocomplementemia. Thus, baseline kidney biopsy in newly diagnosed SLE patients, irrespective of clinical and laboratory manifestations, may aid in guiding therapy.
Indexed as
Identifiers
40126656What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.